Mark O' Neill

Mark O' Neill

Auto-generated profile, based on publicly available information

Mark O' Neill

School of Biomedical Engineering and Imaging Sciences, King’s College London, London, UK

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2008 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
MHMichel Haïssaguerre
Michel Haïssaguerre
NDNicolas Derval
Nicolas Derval
FSFrederic Sacher
Frederic Sacher
LJLaurence Jesel
Laurence Jesel
IDIsabel Deisenhofer
Isabel Deisenhofer
JCJacques Clémenty
Jacques Clémenty
Early repolarization is a common electrocardiographic finding that is generally considered to be benign. Its potential to cause cardiac arrhythmias has been hypothesized from experimental studies, but it is not known whether there is a clinical association with sudden cardiac arrest.

30 March 2024 in EP Europace
Verified
Journal Article
Open access
STStylianos Tzeis
Stylianos Tzeis
EGEdward P Gerstenfeld
Edward P Gerstenfeld
JKJonathan Kalman
Jonathan Kalman
ESEduardo B Saad
Eduardo B Saad
Alireza Sepehri ShamlooAlireza Sepehri Shamloo
Alireza Sepehri Shamloo
STSerge A Trines
Serge A Trines
In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007, the first joint expert consensus document was issued, guiding healthcare professionals involved in catheter or surgical AF ablation. Mounting research evidence and technological advances have resulted in a rapidly changing landscape in the field of catheter and surgical AF ablation, thus stressing the need for regularly updated versions of this partnership which were issued in 2012 and 2017. Seven years after the last consensus, an updated document was considered necessary to define a contemporary framework for selection and management of patients considered for or undergoing catheter or surgical AF ablation. This consensus is a joint effort from collaborating cardiac electrophysiology societies, namely the European Heart Rhythm Association, the Heart Rhythm Society, the Asia Pacific Heart Rhythm Society, and the Latin American Heart Rhythm Society .

8 April 2024 in Heart Rhythm
Verified
Journal Article
Open access
STStylianos Tzeis
Stylianos Tzeis
EGEdward P. Gerstenfeld
Edward P. Gerstenfeld
JKJonathan Kalman
Jonathan Kalman
ESEduardo B. Saad
Eduardo B. Saad
Alireza Sepehri ShamlooAlireza Sepehri Shamloo
Alireza Sepehri Shamloo
EWElaine Y. Wan
Elaine Y. Wan
In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007, the first joint expert consensus document was issued, guiding healthcare professionals involved in catheter or surgical AF ablation. Mounting research evidence and technological advances have resulted in a rapidly changing landscape in the field of catheter and surgical AF ablation, thus stressing the need for regularly updated versions of this partnership which were issued in 2012 and 2017. Seven years after the last consensus, an updated document was considered necessary to define a contemporary framework for selection and management of patients considered for or undergoing catheter or surgical AF ablation. This consensus is a joint effort from collaborating cardiac electrophysiology societies, namely the European Heart Rhythm Association, the Heart Rhythm Society, the Asia Pacific Heart Rhythm Society, and the Latin American Heart Rhythm Society.

8 March 2009 in European Heart Journal
Verified
Journal Article
Open access
PDF file
MOMark D. O'Neill
Mark D. O'Neill
MWMatthew Wright
Matthew Wright
SKSébastien Knecht
Sébastien Knecht
PJPierre Jaïs
Pierre Jaïs
MHMélèze Hocini
Mélèze Hocini
MHMichel Haïssaguerre
Michel Haïssaguerre
Catheter ablation of long-lasting persistent atrial fibrillation (AF) has been performed with varying results using a combination of different techniques. Whether arrhythmia termination during ablation is associated with an improved clinical outcome is controversial. In this prospective study, 153 consecutive patients (56 ± 10 years) underwent catheter ablation of persistent AF (25 ± 33 months) using a stepwise approach with the desired procedural endpoint being AF termination. Repeat ablation was performed for patients with recurrent AF or atrial tachycardia (AT) after a 1 month blanking period. A minimum follow-up of 12 months with repeated Holter monitoring was performed. Atrial fibrillation was terminated in 130 patients (85%). There was a lower incidence of AF in those patients in whom AF was terminated during the index procedure compared with those who had not (5 vs. 39% P < 0.0001, mean follow-up 32 ± 11 months). Seventy-nine patients underwent repeat procedures: 64/130 in the termination group (6 AF, 58 AT) and 15 in the non-termination group (9 AF, 7 AT). After repeat ablation, sinus rhythm was maintained in 95% in whom AF was terminated compared with 52% in those in whom AF could not be terminated. Procedural termination of long-lasting AF by catheter ablation alone is associated with an improved outcome.

1 February 2015 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
USUniv.-Prof. Priv.-Doz. Dr.med.univ. Daniel Scherr
Univ.-Prof. Priv.-Doz. Dr.med.univ. Daniel Scherr
PKPaul Khairy
Paul Khairy
SMShinsuke Miyazaki
Shinsuke Miyazaki
VAValerie Aurillac-Lavignolle
Valerie Aurillac-Lavignolle
PPPatrizio Pascale
Patrizio Pascale
PJPierre Jais
Pierre Jais
Background—: This study aimed to determine 5-year efficacy of catheter ablation for persistent atrial fibrillation (AF) using AF termination as a procedural end point. Methods and Results—: One hundred fifty patients (57±10 years) underwent persistent AF ablation using a stepwise ablation approach (pulmonary vein isolation, electrogram-guided, and linear ablation) with the desired procedural end point being AF termination. Repeat ablation was performed for recurrent AF or atrial tachycardia. AF was terminated by ablation in 120 patients (80%). Arrhythmia-free survival rates after a single procedure were 35.3%±3.9%, 28.0%±3.7%, and 16.8%±3.2% at 1, 2, and 5 years, respectively. Arrhythmia-free survival rates after the last procedure (mean 2.1±1.0 procedures) were 89.7%±2.5%, 79.8%±3.4%, and 62.9%±4.5%, at 1, 2, and 5 years, respectively. During a median follow-up of 58 (interquartile range, 43–73) months after the last ablation procedure, 97 of 150 (64.7%) patients remained in sinus rhythm without antiarrhythmic drugs. Another 14 (9.3%) patients maintained sinus rhythm after reinitiation of antiarrhythmic drugs, and an additional 15 (10.0%) patients regressed to paroxysmal recurrences only. Failure to terminate AF during the index procedure (hazard ratio 3.831; 95% confidence interval, 2.070–7.143; P <0.001), left atrial diameter ≥50 mm (hazard ratio 2.083; 95% confidence interval, 1.078–4.016; P =0.03), continuous AF duration ≥18 months (hazard ratio 1.984; 95% confidence interval, 1.024–3.846; P <0.04), and structural heart disease (hazard ratio 1.874; 95% confidence interval, 1.037–3.388; P =0.04) predicted arrhythmia recurrence. Conclusions—: In patients with persistent AF, an ablation strategy aiming at AF termination is associated with freedom from arrhythmia recurrence in the majority of patients over a 5-year follow-up period. Procedural AF nontermination and specific baseline factors predict long-term outcome after ablation.

8 July 2008 in European Heart Journal
Verified
Journal Article
Closed access
PDF file
SKSébastien Knecht
Sébastien Knecht
MHMélèze Hocini
Mélèze Hocini
MWMatthew Wright
Matthew Wright
NLNicolas Lellouche
Nicolas Lellouche
MOMark D. O'Neill
Mark D. O'Neill
MHMichel Haïssaguerre
Michel Haïssaguerre
Aims This study evaluates the clinical outcome and incidence of left atrial (LA) macro re-entrant atrial tachycardia (AT) in patients in whom persistent atrial fibrillation (AF) terminated during catheter ablation without the need of roof and mitral lines.